These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9024047)
21. Lack of Nephrotoxicity of Hydroxyethyl Starch 130/0.4 When Used in Surgery. Weiskopf RB Anesthesiology; 2015 Aug; 123(2):482-3. PubMed ID: 26196877 [No Abstract] [Full Text] [Related]
22. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch. Wiedermann CJ Intensive Care Med; 2004 Mar; 30(3):519-20; author reply 521. PubMed ID: 14727021 [No Abstract] [Full Text] [Related]
23. Risks of hydroxyethyl starch 130/0.4 in cardiac surgery. Haynes GR J Pharm Pract; 2014 Feb; 27(1):17-8. PubMed ID: 24436438 [No Abstract] [Full Text] [Related]
24. Hetastarch in perioperative volume expansion. Alexander JC Chest; 2003 Oct; 124(4):1194-6. PubMed ID: 14555545 [No Abstract] [Full Text] [Related]
25. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for nonseptic ICU patients. Bayer O; Reinhart K Crit Care; 2015 Oct; 19():357. PubMed ID: 26446864 [No Abstract] [Full Text] [Related]
26. Is Hydroxyethyl Starch 130/0.4 Safe for the Kidney in Noncardiac Surgical Patients? Xue FS; Cui XL; Wang SY Anesthesiology; 2015 Aug; 123(2):481-2. PubMed ID: 26196876 [No Abstract] [Full Text] [Related]
27. Reply to the editor. Navickis RJ; Haynes GR; Wilkes MM J Thorac Cardiovasc Surg; 2013 Jan; 145(1):310-1. PubMed ID: 23244264 [No Abstract] [Full Text] [Related]
32. [Hydroxyethyl starch: Statement of the Presidents of DGAI and the BDA and the President of the DAAF]. Werner C; Geldner G; Koch T Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):437. PubMed ID: 23929160 [No Abstract] [Full Text] [Related]
33. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for non-septic ICU patients: a rebuttal. James M; Joubert I; Michell WL; Nicol A; Navsaria P; Gillespie R Crit Care; 2015 Dec; 19():444. PubMed ID: 26699365 [No Abstract] [Full Text] [Related]
34. Effects of hydroxyethyl starch in critically ill patients. Brunkhorst FM; Schortgen F Br J Anaesth; 2007 Jun; 98(6):842-3; author reply 843-4. PubMed ID: 17519265 [No Abstract] [Full Text] [Related]
35. Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment? Mills GH Br J Anaesth; 2007 Feb; 98(2):157-9. PubMed ID: 17251208 [No Abstract] [Full Text] [Related]
36. The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency. Laake JH; Tønnessen TI; Chew MS; Lipcsey M; Hjelmqvist H; Wilkman E; Pettilä V; Hoffmann-Petersen J; Møller MH; Acta Anaesthesiol Scand; 2018 Jul; 62(6):874-875. PubMed ID: 29658984 [No Abstract] [Full Text] [Related]
39. Coagulopathy with the use of hetastarch in the treatment of vasospasm. Trumble ER; Muizelaar JP; Myseros JS; Choi SC; Warren BB J Neurosurg; 1995 Jan; 82(1):44-7. PubMed ID: 7529301 [TBL] [Abstract][Full Text] [Related]